Skip to main content

Alkyl Amines buy or not

 Not many of us know how to analyse a chemical sector stock. Through this blog, I will try to help you understand the industry in the simplest possible way. Also, we will end the discussion with a comparison of Alkyl Amines with Balaji Amines and other chemical companies like Deepak Nitrite. Table Of Contents 1. Alkyl Amines Business Alkyl Amines Chemicals Ltd. was started   in 1979 by  Mr Yogesh Kothari . It  operates in  a very small segment of the chemical industry -  the   amines  and is currently one of the largest manufacturer in India (around 50%), along with Balaji Amines. Amines play a major role in the pharmaceutical industry and agrochemicals. These are primarily used as a solvent. Alkyl Amines' Business comprises of 3 major segments:- • Aliphatic Amines Methyl amines and Ethyl amines are the aliphatic amines used to make  different types of derivatives. These can also be sold directly and are used by Alkyl Amines t o produce vario...

Contact Us

Interested to collaborate?

Follow us on Instagram for regular updates about stock market, cryptocurrency and any new buzz.


Queries?

You can fill out the below form and help us with your valuable feedback. 



Do share our blog with your known ones who can get benefited from this content.

Thank you for your time!

Comments

Popular posts from this blog

Alkyl Amines buy or not

 Not many of us know how to analyse a chemical sector stock. Through this blog, I will try to help you understand the industry in the simplest possible way. Also, we will end the discussion with a comparison of Alkyl Amines with Balaji Amines and other chemical companies like Deepak Nitrite. Table Of Contents 1. Alkyl Amines Business Alkyl Amines Chemicals Ltd. was started   in 1979 by  Mr Yogesh Kothari . It  operates in  a very small segment of the chemical industry -  the   amines  and is currently one of the largest manufacturer in India (around 50%), along with Balaji Amines. Amines play a major role in the pharmaceutical industry and agrochemicals. These are primarily used as a solvent. Alkyl Amines' Business comprises of 3 major segments:- • Aliphatic Amines Methyl amines and Ethyl amines are the aliphatic amines used to make  different types of derivatives. These can also be sold directly and are used by Alkyl Amines t o produce vario...

Should I buy IEX for bonus | IEX Fundamental Analysis | IEX record date

Indian Energy Exchange (IEX) is in news again due to the announcement of the board confirming the issue of bonus shares on 21st October 2021. So, are you thinking of buying IEX at the current levels? If yes, then this post will cover all you need to know before making your decision. Table Of Contents 1. IEX business The greatest advantage is the  monopoly  IEX holds in its sector, till now (NTPC is also planning to enter the power trading sector). This energy trading industry is in a growth stage and has huge potential. Thus, IEX being the only major player (more than 95% market share) providing a platform for electricity/power trading activities is expected to show further growth in the future. 2. IEX stock fundamentals Next thing you should know are the  fundamentals , which are too good for IEX. From the company's annual reports, let us do a 6 pointer analysis :- Sales - Increasing every year ✅ Profits - In an uptrend ✅ Operating Profit Margin - Above 80%  ✅...

Should I buy Laurus Labs | Laurus Labs fundamental analysis | Laurus Labs buy price

Interested in a stock from Pharma sector? Ready to take a little higher risk? Looking out for a share capable of generating multi bagger returns? Then, this stock is for you. Table Of Contents Laurus Labs business Is Laurus Labs a good company? Laurus Labs is a small cap pharmaceutical company operating as a contract manufacturer(CDMO business), involved in APIs (low cost advantage) and continuously growing in terms of new products and patents. Laurus Labs Annual Reports On analysis of annual reports (feel free to skip this section, although I have tried to make it simple to understand)- The EBITDA increased considerably(150+%) due to forward integration in formulations. High R&D capabilities have aided in further cost cutting(50%) and capturing market share in new products(30+%) over the time. The ROE and ROCE of the company are up to the mark consistently (even if we ignore the covid scenario). Why is Laurus Labs stock price increasing? Anoth...